Cargando…
Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism
The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 have not been completely deciphered. We set out to investigate the physiological importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displace...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489211/ https://www.ncbi.nlm.nih.gov/pubmed/36073784 http://dx.doi.org/10.7554/eLife.69061 |
_version_ | 1784792828294987776 |
---|---|
author | Bridges, James P Safina, Caterina Pirard, Bernard Brown, Kari Filuta, Alyssa Panchanathan, Ravichandran Bouhelal, Rochdi Reymann, Nicole Patel, Sejal Seuwen, Klaus Miller, William E Ludwig, Marie-Gabrielle |
author_facet | Bridges, James P Safina, Caterina Pirard, Bernard Brown, Kari Filuta, Alyssa Panchanathan, Ravichandran Bouhelal, Rochdi Reymann, Nicole Patel, Sejal Seuwen, Klaus Miller, William E Ludwig, Marie-Gabrielle |
author_sort | Bridges, James P |
collection | PubMed |
description | The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 have not been completely deciphered. We set out to investigate the physiological importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor activation. To examine this hypothesis, we characterized tethered agonist-mediated activation of GPR116 in vitro and in vivo. A knock-in mouse expressing a non-cleavable GPR116 mutant phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor activation is indispensable for function in vivo. Using site-directed mutagenesis and species-swapping approaches, we identified key conserved amino acids for GPR116 activation in the tethered agonist sequence and in extracellular loops 2/3 (ECL2/3). We further highlight residues in transmembrane 7 (TM7) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model supporting tethered agonist:ECL2 interactions for GPR116 activation. |
format | Online Article Text |
id | pubmed-9489211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-94892112022-09-21 Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism Bridges, James P Safina, Caterina Pirard, Bernard Brown, Kari Filuta, Alyssa Panchanathan, Ravichandran Bouhelal, Rochdi Reymann, Nicole Patel, Sejal Seuwen, Klaus Miller, William E Ludwig, Marie-Gabrielle eLife Cell Biology The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR ADGRF5/GPR116 have not been completely deciphered. We set out to investigate the physiological importance of autocatalytic cleavage upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor activation. To examine this hypothesis, we characterized tethered agonist-mediated activation of GPR116 in vitro and in vivo. A knock-in mouse expressing a non-cleavable GPR116 mutant phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor activation is indispensable for function in vivo. Using site-directed mutagenesis and species-swapping approaches, we identified key conserved amino acids for GPR116 activation in the tethered agonist sequence and in extracellular loops 2/3 (ECL2/3). We further highlight residues in transmembrane 7 (TM7) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model supporting tethered agonist:ECL2 interactions for GPR116 activation. eLife Sciences Publications, Ltd 2022-09-08 /pmc/articles/PMC9489211/ /pubmed/36073784 http://dx.doi.org/10.7554/eLife.69061 Text en © 2022, Bridges et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Bridges, James P Safina, Caterina Pirard, Bernard Brown, Kari Filuta, Alyssa Panchanathan, Ravichandran Bouhelal, Rochdi Reymann, Nicole Patel, Sejal Seuwen, Klaus Miller, William E Ludwig, Marie-Gabrielle Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title | Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title_full | Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title_fullStr | Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title_full_unstemmed | Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title_short | Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist-mediated activation mechanism |
title_sort | regulation of pulmonary surfactant by the adhesion gpcr gpr116/adgrf5 requires a tethered agonist-mediated activation mechanism |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489211/ https://www.ncbi.nlm.nih.gov/pubmed/36073784 http://dx.doi.org/10.7554/eLife.69061 |
work_keys_str_mv | AT bridgesjamesp regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT safinacaterina regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT pirardbernard regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT brownkari regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT filutaalyssa regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT panchanathanravichandran regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT bouhelalrochdi regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT reymannnicole regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT patelsejal regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT seuwenklaus regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT millerwilliame regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism AT ludwigmariegabrielle regulationofpulmonarysurfactantbytheadhesiongpcrgpr116adgrf5requiresatetheredagonistmediatedactivationmechanism |